Seedlings Life Science Ventures, LLC – Trademark Portfolio
Entity Type: 16
Seedlings Life Science Ventures, LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PREVA, SEEDLINGS, and SEEDLINGS LIFE SCIENCE VENTURES LLC. The owner is based in New York, NY.
230 East 15th Street, #1A
New York, NY 10003
Showing of trademarks Trademarks
Trademark Classifications
Seedlings Life Science Ventures, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Seedlings Life Science Ventures, LLC have?
Seedlings Life Science Ventures, LLC has 10 U.S. trademarks filed with the USPTO. Of these, 3 registered, 6 abandoned, 1 cancelled.
What trademark classes does Seedlings Life Science Ventures, LLC file in?
Seedlings Life Science Ventures, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Seedlings Life Science Ventures, LLC's most well-known trademarks?
Seedlings Life Science Ventures, LLC's registered trademark portfolio includes well-known marks such as PREVA, SEEDLINGS, and SEEDLINGS LIFE SCIENCE VENTURES LLC. These are among 3 currently registered trademarks in the portfolio.
What is Seedlings Life Science Ventures, LLC's trademark registration success rate?
Seedlings Life Science Ventures, LLC has a 30% trademark registration rate, with 3 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.